甲福明使用与急性呼吸衰竭死亡率之间的相关性:一个回顾性ICU队列研究
Yunlin Yang1, Jinfeng Liu2, Yi Hou2
1Department of Clinical Pharmacy, Shifang People's Hospital, Shifang, Sichuan, China.
Frontiers in pharmacology
|September 11, 2025
概括
在急性呼吸衰竭 (ARF) 患者的重症监护室 (ICU) 中,甲福明的使用显著降低了死亡率. 这表明,在重症患者中,甲福明可能会提供超出血糖控制的生存益处.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 调查甲福明对急性呼吸衰竭 (ARF) 患者在重症监护病房 (ICU) 的结局的影响.
- 评估甲福明使用与住院死亡率和重症ARF患者的预后之间的关联.
研究的目的:
- 为了确定甲福明的使用是否与急性呼吸衰竭患者的死亡率降低有关.
- 评估甲胺在重症监护室对ARF患者的预后影响.
主要方法:
- 使用MIMIC-IV数据库进行回顾性队列研究.
- 倾向性得分匹配 (PSM) 和机器学习用于混调整.
- 卡普兰-梅尔曲线,考克斯模型,以及用于生存和死亡率分析的逻辑回归.
主要成果:
- 甲胺使用与显著降低住院死亡率 (OR=0.202) 和ICU死亡率 (OR=0.245) 相关.
- 减少30天 (HR=0.199) 和90天 (HR=0.230) 的全因死亡率,在甲福明使用者中观察到.
- 卡普兰-梅尔生存分析证实,使用甲福明的患者的生存率更好 (p < 0.001).
结论:
- 甲福明的使用与急性肺炎的ICU患者的短期死亡率降低有关.
- 在重症患者群体中,甲胺可能会提供生存益处,可能独立于血糖控制.
- 建议进行进一步的前性研究,以证实这些发现并指导临床应用.
更多相关视频
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
1.1K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
535
相关概念视频
Acute Respiratory Failure-V
467
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
467
Oral Hypoglycemic Agents: Biguanides and Glitazones
588
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
588
Acute Respiratory Failure-I
869
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
869
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-III
797
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
797
Acute Respiratory Failure-IV
521
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
521
